Exploratory Clinical Development World Europe 2012

Engage with thought leaders innovating early development

Now in its 6th year, Exploratory Clinical Development World Europe has established itself as the largest & most influential European event for top pharma & biotech representatives working within exploratory development & early phase clinical trials.

In 2011 nearly 250 people attended to hear and discuss strategy and solutions to overcome bottlenecks and fast track early development. In 2012 we have built on this success and will once again be providing participants with a comprehensive review of possible solutions to alleviating the challenges. You will hear thought leaders and experts discuss key topics.

New for 2012 –

Pharmaceutical and Biotech registration reduced by 50%!

Clinical development strategies in phase I

Exploratory Clinical Development World Europe will focus on:

-New paradigms in exploratory clinical development
-Open innovation in pharma
-Managing the transition between preclinical and first in man studies
-Advancing proof of concept tools and approaches
-Managing risk in early development
-Review of innovative clinical trial design
-Regulatory status and review
-Evaluation of biomarkers in early development
-Improving safety pharmacology data
- Modelling and simulation

Who should attend:

-Translational Medicine
-Clinical Development
-Medical Director
-Exploratory Development
-PK/PD
-Phase I Trials
-Clinical Pharmacology
-Clinical Research
-Research & Development
-Clinical Trials